title: Ecstasy use-Parkinson's disease link tenuous.
authors.forename: Lisa
authors.initials: L
authors.lastname: Jerome
authors.forename: Rick
authors.initials: R
authors.lastname: Doblin
authors.forename: Michael
authors.initials: M
authors.lastname: Mithoefer
mesh_terms: D000284:Administration, Oral; D018759:Adrenergic Uptake Inhibitors / Q000633:toxicity*; D004305:Dose-Response Relationship, Drug; D006213:Hallucinogens / Q000633:toxicity*; D006801:Humans; D007279:Injections, Subcutaneous; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000633:toxicity*; D010302:Parkinson Disease, Secondary / Q000139:chemically induced*; D012306:Risk
chemical_list: D018759:Adrenergic Uptake Inhibitors; D006213:Hallucinogens; D018817:N-Methyl-3,4-methylenedioxyamphetamine